Literature DB >> 34807376

MicroRNA let-7b inhibits hepatitis C virus and induces apoptosis in human hepatoma cells.

Marzieh Jamalidoust1, Maryam Shafaati2, Mehdi Kalani3, Maryam Zare3, Mazyar Ziyeayan3.   

Abstract

BACKGROUND: Small non-coding RNAs have emerged as essential modulators of viral infections such as hepatitis C virus (HCV). Cellular miRNAs directly regulate the viral infectivity and indirectly by targeting virus-host factors. The current study investigates the inhibitory effect of let-7b miRNA on HCV replication in the Hepatocarcinoma cell line (Huh7.5). METHODS AND
RESULTS: The algorithm-based search revealed that let-7b, a high score microRNA, has target sequences on the HCV genome. The Huh7.5 cells were stably transduced with let-7b lentiviral vectors (Huh7.5/let-7b) and mock (Huh7.5/scrambled). The expression of the let-7b level was assessed by real-time PCR assay and Red fluorescence microscope. A dual-luciferase assay was conducted to evaluate the liver-specific let-7b and HCV genome interaction. In the next step, for establishing HCVcc, Full-length HCV-RNA was transduced to naïve Huh7.5, Huh7.5/scrambled, and Huh7.5/let-7b cells. The results of in silico analysis and dual-luciferase reporter assay exhibited a specific interaction of HCV-NS5B and let-7b. Real-time PCR analysis revealed that in contrast to infected naïve Huh7.5 cells and Huh7.5/scrambled, a significant decrease in HCV-RNA load was seen in Huh7.5/let-7b cells. On the other hand, the Flow Cytometry test showed that let-7b could significantly induce the apoptosis pathway in Huh7.5/let-7b.
CONCLUSIONS: The results also suggest that let-7b, as a target of the HCV genome, potentially reduces HCV replication and raises cell apoptosis rate. We suggest that let-7b directly downregulates HCV replication and may serve as a unique antiviral therapy.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Hepatitis C virus; Huh7.5; MicroRNA let-7b

Mesh:

Substances:

Year:  2021        PMID: 34807376     DOI: 10.1007/s11033-021-06955-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  2 in total

Review 1.  Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline.

Authors:  Seyed Moayed Alavian; Behzad Hajarizadeh; Kamran Bagheri Lankarani; Heidar Sharafi; Nasser Ebrahimi Daryani; Shahin Merat; Minoo Mohraz; Masoud Mardani; Mohamad Reza Fattahi; Hossein Poustchi; Mehri Nikbin; Mahmood Nabavi; Peyman Adibi; Masood Ziaee; Bita Behnava; Mohammad Saeid Rezaee-Zavareh; Massimo Colombo; Hatef Massoumi; Abdul Rahman Bizri; Bijan Eghtesad; Majid Amiri; Ali Namvar; Khashayar Hesamizadeh; Reza Malekzadeh
Journal:  Hepat Mon       Date:  2016-08-13       Impact factor: 0.660

2.  Silencing Lin28 promotes apoptosis in colorectal cancer cells by upregulating let‑7c targeting of antiapoptotic BCL2L1.

Authors:  Haogang Zhang; Yaguang Zong; Gongcai Qiu; Ruichun Jia; Xunzheng Xu; Fujing Wang; Dequan Wu
Journal:  Mol Med Rep       Date:  2018-01-25       Impact factor: 2.952

  2 in total
  1 in total

Review 1.  Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches.

Authors:  Ester Badami; Rosalia Busà; Bruno Douradinha; Giovanna Russelli; Vitale Miceli; Alessia Gallo; Giovanni Zito; Pier Giulio Conaldi; Gioacchin Iannolo
Journal:  World J Gastroenterol       Date:  2022-06-14       Impact factor: 5.374

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.